Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Talis Biomedical Corporation stock (Talis Biomedical Corporation)

Buy Talis Biomedical Corporation stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Talis Biomedical Corporation is a medical devices business based in the US. Talis Biomedical Corporation shares (TLIS) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $1.70 – a decrease of 7.61% over the previous week. Talis Biomedical Corporation employs 99 staff and has a trailing 12-month revenue of around $408,000.

Our top picks for where to buy Talis Biomedical stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%

How to buy Talis Biomedical Corporation stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – TLIS. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Talis Biomedical Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Product USFST Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Finder score
Stocks, ETFs
$0
$0
N/A
Earn up to $300
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Talis Biomedical Corporation stock price (PINK: TLIS)

Use our graph to track the performance of TLIS stocks over time.

Talis Biomedical Corporation shares at a glance

Information last updated 2024-12-19.
Latest market close$1.70
52-week range$1.37 - $9.60
50-day moving average $1.74
200-day moving average $5.74
Wall St. target price$5.00
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-28.02

Talis Biomedical Corporation price performance over time

Historical closes compared with the close of $1.7275 from 2024-12-20

1 week (2024-12-17) -6.11%
1 month (2024-11-22) 2.22%
3 months (2024-09-24) -14.05%
6 months (2024-06-24) -79.77%
1 year (2023-12-22) -79.06%
2 years (2022-12-23) -76.01%
3 years (2021-12-23) 63.9
5 years (2019-12-20) N/A

Talis Biomedical Corporation financials

Revenue TTM $408,000
Gross profit TTM $-149,398,000
Return on assets TTM -29.59%
Return on equity TTM -70.48%
Profit margin 0%
Book value $26.68
Market Capitalization $3.4 million

TTM: trailing 12 months

Talis Biomedical Corporation share dividends

We're not expecting Talis Biomedical Corporation to pay a dividend over the next 12 months.

You may also wish to consider:

Have Talis Biomedical Corporation's shares ever split?

Talis Biomedical Corporation's shares were split on a 1:15 basis on 5 July 2023 . So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Talis Biomedical Corporation shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Talis Biomedical Corporation shares which in turn could have impacted Talis Biomedical Corporation's share price.

Talis Biomedical Corporation share price volatility

Over the last 12 months, Talis Biomedical Corporation's shares have ranged in value from as little as $1.37 up to $9.6. A popular way to gauge a stock's volatility is its "beta".

TLIS.US volatility(beta: 1.56)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Talis Biomedical Corporation's is 1.561. This would suggest that Talis Biomedical Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put Talis Biomedical Corporation's beta into context you can compare it against those of similar companies.

Talis Biomedical Corporation overview

Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois. .

Frequently asked questions

What percentage of Talis Biomedical Corporation is owned by insiders or institutions?
Currently 8.306% of Talis Biomedical Corporation shares are held by insiders and 41.988% by institutions.
How many people work for Talis Biomedical Corporation?
Latest data suggests 99 work at Talis Biomedical Corporation.
When does the fiscal year end for Talis Biomedical Corporation?
Talis Biomedical Corporation's fiscal year ends in December.
Where is Talis Biomedical Corporation based?
Talis Biomedical Corporation's address is: 1375 West Fulton Market, Chicago, IL, United States, 60607
What is Talis Biomedical Corporation's ISIN number?
Talis Biomedical Corporation's international securities identification number is: US87424L1089

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site